A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol

NCT04773366 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Prednisone+Cytarabine+vincristine
DRUG: Prednisone+Cytarabine+vincristine+Mercaptopurine
DRUG: Prednisone+Cytarabine+vincristine+Mercaptopurine
DRUG: Prednisone+Cytarabine+vincristine
DRUG: Prednisone+vincristine+Mercaptopurine
DRUG: Prednisone+vincristine
DRUG: Prednisone+vincristine
OTHER: Local therapy

Sponsor

Shanghai Children's Medical Center